Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the adequacy of supplies of the HRT drug, Estradot.

We are aware of ongoing supply issues with some hormone replacement therapy (HRT) preparations for a variety of reasons. Although some HRT products are still affected by supply issues, alternatives remain available, and the overall supply situation has been improving since February 2020 and will continue to improve over the coming months. We are continuing to work closely with all suppliers to resolve the issues as quickly as possible and maintain overall supply to patients across the United Kingdom.

Novartis, the manufacturer of Estradot confirmed that it has not experienced manufacturing issues and that Estradot supplies continue to remain available. However, the company has experienced an increase in demand, due to shortages affecting other HRT products so has been managing and monitoring supplies closely.